Wordt geladen...
Prognostic impact of CDKN2A/B deletion, TERT mutation, and EGFR amplification on histological and molecular IDH-wildtype glioblastoma
BACKGROUND: We aimed to evaluate the clinical outcomes of molecular glioblastoma (mGBM) as compared to histological GBM (hGBM) and to determine the prognostic impact of TERT mutation, EGFR amplification, and CDKN2A/B deletion on isocitrate dehydrogenase (IDH)-wildtype GBM. METHODS: IDH-wildtype GBM...
Bewaard in:
| Gepubliceerd in: | Neurooncol Adv |
|---|---|
| Hoofdauteurs: | , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Oxford University Press
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7668466/ https://ncbi.nlm.nih.gov/pubmed/33235995 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdaa126 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|